Novo and Orlando Health helped the haemodialysis technology provider increase its overall funding to $350m since it was spun off by IMI.
Pharmaceutical firm Novo co-led a $245m series D round yesterday for Quanta Dialysis Technologies, a UK-based medical device producer spun off from engineering firm IMI.
The round was co-led by hedge fund manager Glenview Capital and included healthcare provider Orlando Health, BlackRock, Eldridge, Sands Capital, Millennium Management, Monashee Investment Management, Puhua Capital, Segulah Medical Acceleration, Ancora Holdings, Wellington Partners, Btov, Seroba Life Sciences and The Grands.
Formerly known as Quanta Fluid Solutions, Quanta has built a haemodialysis device called SC+ which…
